[1]邓亚琴.血清胆碱酯酶、胆汁酸和总胆红素联合检测在肝硬化和病毒性肝炎中的诊断价值[J].医学信息,2024,37(03):145-148.[doi:10.3969/j.issn.1006-1959.2024.03.030]
　DENG Ya-qin.Diagnostic Value of Combined Detection of Serum Cholinesterase,Bile Acid and Total Bilirubin in Cirrhosis and Viral Hepatitis[J].Journal of Medical Information,2024,37(03):145-148.[doi:10.3969/j.issn.1006-1959.2024.03.030]
点击复制

血清胆碱酯酶、胆汁酸和总胆红素联合检测在肝硬化和病毒性肝炎中的诊断价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年03期
页码:
145-148
栏目:
诊疗技术
出版日期:
2024-02-01

文章信息/Info

Title:
Diagnostic Value of Combined Detection of Serum Cholinesterase,Bile Acid and Total Bilirubin in Cirrhosis and Viral Hepatitis
文章编号:
1006-1959（2024）03-0145-04
作者:
邓亚琴
（金溪县人民医院检验科，江西 金溪 344800）
Author(s):
DENG Ya-qin
(Department of Laboratory,Jinxi County People’s Hospital,Jinxi 344800,Jiangxi,China)
关键词:
胆碱酯酶; 胆汁酸; 总胆红素; 肝硬化; 病毒性肝炎
Keywords:
Cholinesterase; Bile acid; Total bilirubin; Cirrhosis; Viral hepatitis
分类号:
R575.2
DOI:
10.3969/j.issn.1006-1959.2024.03.030
文献标志码:
A
摘要:
目的 研究血清胆碱酯酶（ChE）、胆汁酸（TBA）、总胆红素（TBIL）联合检测在肝硬化和病毒性肝炎中的诊断价值。方法 选取2020年4月-2022年4月我院诊治的43例肝硬化（观察A组）患者和43例病毒性肝炎（观察B组）患者为研究对象，并选取同期在我院体检健康者43例为对照组，均进行血清ChE、TBA、TBIL检测，比较三组血清ChE、TBA、TBIL水平；观察B组和观察A组以上指标阳性检出率；观察A组不同肝功能分级患者以上指标水平以及不同指标对肝硬化和病毒性肝炎的诊断效能（敏感度、特异度）。结果 观察A组、观察B组ChE均低于对照组，TBA、TBIL均高于对照组（P＜0.05），且观察A组ChE低于观察B组，TBA、TBIL均高于观察B组（P＜0.05）；观察A组血清ChE、TBA、TBIL阳性率均高于观察B组（P＜0.05）；观察A组Child-pugh C级患者ChE低于A级、B级患者，TBA、TBIL均高于A级、B级患者（P＜0.05），且B级ChE低于A级患者，TBA、TBIL均高于A级（P＜0.05）；ChE+TBA+TBIL联合检测诊断肝硬化和病毒性肝炎的敏感度、特异度均高于ChE、TBA、TBIL单独检测（P＜0.05）。结论 病毒性肝炎和肝硬化患者血清ChE、TBA、TBIL水平存在差异，且ChE、TBA、TBIL联合检测可提高肝硬化和病毒性肝炎诊断效能，并且可一定程度判定肝硬化患者肝功能损伤程度，为临床诊治提供可靠参考依据。
Abstract:
Objective To study the diagnostic value of combined detection of serum cholinesterase (ChE), bile acid (TBA) and total bilirubin (TBIL) in cirrhosis and viral hepatitis.Methods Forty-three patients with cirrhosis (observation group A) and 43 patients with viral hepatitis (observation group B) diagnosed and treated in our hospital from April 2020 to April 2022 were selected as the research objects, and 43 healthy people who underwent physical examination in our hospital during the same period were selected as the control group. Serum ChE, TBA and TBIL were detected, and the levels of serum ChE, TBA and TBIL were compared among the three groups. The positive detection rates of the above indexes in group B and group A were observed. The levels of the above indicators in patients with different liver function grades in group A and the diagnostic efficacy (sensitivity and specificity) of different indicators for cirrhosis and viral hepatitis were observed.Results The level of ChE in observation group A and observation group B was lower than that in control group, and the levels of TBA and TBIL were higher than those in control group (P<0.05). The level of ChE in observation group A was lower than those in observation group B, and the levels of TBA and TBIL were higher than those in observation group B (P<0.05). The positive rates of serum ChE, TBA and TBIL in observation group A were higher than those in observation group B (P<0.05). The ChE of Child-pugh C patients in observation group A was lower than that of Child-pugh A and Child-pugh B patients, and TBA and TBIL were higher than those of Child-pugh A and Child-pugh B patients (P<0.05). The ChE of Child-pugh B patients was lower than that of Child-pugh A patients, and TBA and TBIL were higher than those of Child-pugh A patients (P<0.05). The sensitivity and specificity of combined detection of ChE+TBA+TBIL in the diagnosis of cirrhosis and viral hepatitis were higher than those of ChE, TBA and TBIL alone (P<0.05).Conclusion There are differences in serum ChE, TBA and TBIL levels between patients with viral hepatitis and cirrhosis, and the combined detection of ChE, TBA and TBIL can improve the diagnostic efficacy of cirrhosis and viral hepatitis, and can determine the degree of liver function damage in patients with cirrhosis to a certain extent, providing a reliable reference for clinical diagnosis and treatment.

参考文献/References:

[1]钟瑞雪,周少雄,沈永坚,等.四项生化指标在肝病诊断中的应用[J].现代诊断与治疗,2007,18(3):139-140.[2]Becker H,Stahmeyer JT,Manns MP,et al.Laboratory requirements to diagnose viral hepatitis under the development of guidelines[J].Z Gastroenterol,2017,55(1):32-38．[3]文关良.肝炎肝硬化患者血清CHE、ALB、CHO水平检测在肝功能评估中的临床应用价值[J].检验医学与临床,2017,14(18):2741-2742．[4]宋岩,杨虎,林琳,等.白蛋白-胆红素评分在自身免疫性肝炎肝硬化预后评估中的应用[J].中华肝脏病杂志,2019,27(10):772-776．[5]韦丽梅.四项生化指标检验在肝硬化和病毒性肝炎中的应用价值分析[J].吉林医学,2019,40(2):361-362.[6]Prabina P,Jayanthi S,Krishna Murthy C,et al.A Study on Hepatitis B Viral Seromarkers and Associated Risk Factors among the Patients Suffering from Acute and Chronic Hepatitis B Infection[J].Int J Appl Basic Med Res,2019,9(4):206-211.[7]易佳音,张淑凤,冯慧芬,等.血清胆汁酸谱系测定在肝硬化诊断中的应用价值[J].郑州大学学报(医学版),2019,54(6):922-926．[8]刘彩红.对生化检验项目用于肝硬化疾病诊断中的临床价值进行分析[J].国际感染病学(电子版),2020,9(1):93-94．[9]乐华文,王依屹.凝血、纤溶和抗凝指标在慢性乙型肝炎病情进展中的变化规律[J].检验医学与临床,2020,17(6):755-757．[10]李玲丽,刘代忠.不同程度乙肝肝硬化患者Ig、血清sP-selectin、sICAM-1水平的变化及意义[J].国际免疫学杂志,2019,42(4):387-390.[11]王珍珠,孟坤.血清中免疫球蛋白检验在乙型肝炎诊治中的意义及对预后的影响[J].延安大学学报(医学科学版),2019,17(2):81-83,110.[12]侯玉丽,高梦丹,郭鸿雁,等.白蛋白-胆红素指数与血氨联合检测对肝硬化并发肝性脑病的诊断价值评估[J].中华医学杂志,2018,98(2):127-131．[13]翟永贞,岳阳阳,丁德平,等.血清前白蛋白联合终末期肝病模型评分评估失代偿期肝硬化患者预后的临床价值[J].中华肝脏病杂志,2017,25(7):533-535．[14]郭飞波.肝硬化伴肝癌患者血氨、甲胎蛋白、胆碱酯酶、肝纤维化指标与Child-Pugh分级的相关性[J].中国免疫学杂志,2017,33(8):1209-1212,1217．[15]陈爱珍.乙型肝炎患者血清免疫球蛋白水平临床检验结果分析[J].河南预防医学杂志,2020,31(2):91-92,111.[16]陈黛琪,洪浚锋,黄志昂.乙型肝炎诊断中患者实施血清中免疫球蛋白检验的效果观察及IgA水平影响分析[J].中国医药科学,2020,10(5):180-182.[17]郭杰.慢性乙型肝炎患者免疫球蛋白检测的临床意义分析[J].实用检验医师杂志,2020,12(4):207-209.[18]尚娟.乙型肝炎患者机体血清免疫球蛋白水平的表达及检测价值[J].黑龙江中医药,2020,49(4):142-143.[19]王爽,柯盈月,李权伦,等.血清前白蛋白、胆碱酯酶、凝血酶原活动度水平联合Child-Pugh分级对肝硬化患者预后的判断[J].临床消化病杂志,2017,29(6):346-349．

相似文献/References:

[1]陈 敏,侯洪伟.肝切除术后肝功能失代偿的相关风险指标分析[J].医学信息,2019,32(15):83.[doi:10.3969/j.issn.1006-1959.2019.15.026]
　CHEN Min,HOU Hong-wei.Analysis of Risk Indicators Related to Liver Function Decompensation after Hepatectomy[J].Journal of Medical Information,2019,32(03):83.[doi:10.3969/j.issn.1006-1959.2019.15.026]
[2]蔡秀媛,吴春城,梁惠卿,等.非酒精性脂肪性肝病中医证型与客观指标的相关性[J].医学信息,2020,33(09):21.[doi:10.3969/j.issn.1006-1959.2020.09.008]
　CAI Xiu-yuan,WU Chun-cheng,LIANG Hui-qing,et al.Correlation Between TCM Syndromes of Nonalcoholic Fatty Liver Disease and Objective Indexes[J].Journal of Medical Information,2020,33(03):21.[doi:10.3969/j.issn.1006-1959.2020.09.008]
[3]王 轩,韩春凤,王立强.血液灌流治疗乐果中毒的临床疗效及住院费用研究[J].医学信息,2020,33(13):121.[doi:10.3969/j.issn.1006-1959.2020.13.035]
　WANG Xuan,HAN Chun-feng,WANG Li-qiang.Study on the Clinical Effect and Hospitalization Cost of Blood Perfusion for Dimethoate Poisoning[J].Journal of Medical Information,2020,33(03):121.[doi:10.3969/j.issn.1006-1959.2020.13.035]
[4]宋少娟,苏国华.血清总胆汁酸、胆碱酯酶和前白蛋白检测在肝病诊断中应用探析[J].医学信息,2021,34(23):9.[doi:10.3969/j.issn.1006-1959.2021.23.002]
　SONG Shao-juan,SU Guo-hua.Application of Serum Total Bile Acid, Cholinesterase and Prealbumin Detection in the Diagnosis of Liver Disease[J].Journal of Medical Information,2021,34(03):9.[doi:10.3969/j.issn.1006-1959.2021.23.002]
[5]陈锐聪,香钰婷,李仲均.妊娠期糖尿病孕妇血液中不同类型物质的代谢组学特点[J].医学信息,2023,36(19):185.[doi:10.3969/j.issn.1006-1959.2023.19.042]
　CHEN Rui-cong,XIANG Yu-ting,LI Zhong-jun.Metabolomics Characteristics of Different Types of Substances in the Blood of Pregnant Women with Gestational Diabetes Mellitus[J].Journal of Medical Information,2023,36(03):185.[doi:10.3969/j.issn.1006-1959.2023.19.042]
[6]杨 璈,钟世林.法尼醇X受体对血糖代谢的调控作用[J].医学信息,2025,38(06):168.[doi:10.3969/j.issn.1006-1959.2025.06.032]
　YANG Ao,ZHONG Shilin.Regulation of Farnesoid X Receptor on Blood Glucose Metabolism[J].Journal of Medical Information,2025,38(03):168.[doi:10.3969/j.issn.1006-1959.2025.06.032]

更新日期/Last Update: 1900-01-01